Kogan, SC; Doherty M; Gitschier J. An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA Sequences: Application to Hemophilia A. N Engl J Med 1987, 317:985-990.
Brown, DE*; Kogan, SC*; Lagasse, E; Weissman, IL; Alcalay, M; Pelicci, P; Atwater, S; Bishop, JM. A PML-RARATransgene Initiates Murine Acute Promyelocytic Leukemia. Proc Natl Acad Sci USA 1997, 94:2551-2556.
*These authors contributed equally to this work.
Kogan, SC; Ward, JM; Anver, MR; Berman, JJ; Brayton, C; Cardiff, RD; Carter, JS; de Coronado, S; Downing, JR; Fredrickson, TN; Haines, DC; Harris, AW; Harris, NL; Hiai, H; Jaffe, ES; MacLennan, ICM; Pandolfi, PP; Pattengale, PK; Perkins, AS; Simpson, RM; Tuttle, MS; Wong, JF; Morse, HC III. Bethesda Proposals for Classification of Non-Lymphoid Hematopoietic Neoplasms in Mice. Blood 2002, 100:238-245
Truong, BH; Lee, YJ; Lodie, TA; Park, DJ; Perrotti, D; Watanabe, N; Koeffler, HP; Nakajima, H; Tenen, DG; Kogan, SC. CCAAT/Enhancer Binding Proteins Repress the Leukemic Phenotype of Acute Myeloid Leukemia. Blood, 2003, 101:1141-1148.
Sohal, J; Phan, VT; Chan, PV; Davis, EM; Patel, B; Kelly, LM; Abrams, T; O’Farrell, AM; Gilliland, DG; LeBeau, MM; Kogan, SC. A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. Blood, 2003, 101: 3188-3197.
Phan, VT; Shultz, DB; Truong, BH; Blake, TJ; Brown, AL; Gonda, TJ; Le Beau, MM; Kogan, SC. Cooperation of Cytokine Signaling with Chimeric Transcription Factors in Leukemogenesis: PML-RARα blocks growth factor mediated differentiation. Mol Cell Biol, 2003, 23: 4573-4585.
Le Beau, MM; Davis, EM; Patel, B; Phan, VT; Sohal, J; Kogan, SC. Recurring Chromosomal Abnormalities in Leukemia in PML-RARA Transgenic Mice Identify Cooperating Events and Genetic Pathways to Acute Promyelocytic Leukemia. Blood, 2003, 102:1072-1074.
Zhu, J; Zhou, J; Peres, L; Riacoux, F; Honoré, N; Kogan, S; de Thé, H. A Sumolation site in PML/RARA is Essential for Leukemic Transformation. Cancer Cell 2005, 7:143-153.
Sternsdorf, T; Phan, V; Maunakea, ML; Ocampo-Bayuga, C; Sohal, J; Silletto, A; Galimi, F; LeBeau, MM; Evans, RM; Kogan, SC. Forced Retinoic Acid Receptor alpha Homodimers Prime Mice for APL-like Leukemia. Cancer Cell, 2006, 9:81-94.
Lee, YJ; Jones, LC; Timchenko, NA; Perrotti, D; Tenen, DG; Kogan, SC. CCAAT/enhancer binding proteins alpha and epsilon cooperate with all-trans retinoic acid in therapy but they differ in their anti-leukemic activities. Blood, 2006, 108:2416-1249.
Forsberg, C; Serwold, T; Kogan, S; Weissman, IL; Passegué, E. New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3(+) multipotent hematopoietic progenitors. Cell, 2006, 126:415-426.
Wendel, HG; Malina, A; Zhao, Z; Zender, L; Kogan, SC; Cordon-Cardo, C; Pelletier, J; Lowe, SW. Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Cancer Research, 2006, 66:7639-7646.
Lee, BD; Sevcikova, S; KoganSC. Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic mice. Leukemia Research, 2007, 31:1139-1142.
Omidvar, N; Kogan, S; Beurlet, S; le Pogam, C; Janin, A; West, R; Noguera, ME; Reboul, M; Soulie, A; Leboeuf, C; Setterblad, N; Felsher, D; Lagasse, E; Mohamedali, A; Thomas, NSB; Fenaux, P; Fontenay, M; Pla, M; Mufti, GJ; Weissman, I; Chomienne, C; Padua, RA. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia. Cancer Research, 2007, 67:11657-11667.
Mills, J; Hippo, Y; Robert, F; Chen, SM; Malina, A; Lin, CJ; Trojahn, U; Wendel, HG; Charest, A; Bronson, RT, Kogan, SC; Nadon, R; Housman, DE; Lowe, SW; Pelletier, J. mTORC1 promotes survival through translational control of Mcl-1. Proceedings of the National Academy of Sciences U S A , 2008, 105:10853-10858.
Viatour, P; Somervaille, TC; Venkatasubrahmanyam, S; Kogan, S; McLaughlin, ME; Weissman, IL; Butte, AJ; Passegué, E; Sage, J. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell, 2008, 3:416-428.
Zuber, J; Radtke, I; Pardee, T; Zhao, Z; Rappaport AR; Luo, W; McCurrach, ME; Yang, M; Dolan, E; Kogan, SC; Downing, JR; Lowe, SW. Mouse models of human AML accurately predict chemotherapy response. Genes & Development, 2009, 23:877-889.
Lauchle, JO; Kim, D; Le, DT; Akagi, K; Crone, M; Krisman, K; Warner, K; Bonifas, JM; Li, Q; Coakley, KM; Diaz-Flores, E; Gorman, M; Przybranowsk,i S; Tran, M; Kogan, SC; Roose, JP; Copeland, NG; Jenkins, NA; Parada, L; Wolff, L; Sebolt-Leopold, J; Shannon, K. Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras. Nature, 2009, 461:411-414.
Dail, M, Li, Q, McDaniel, A, Wong, J, Akagi, K; Huang, B; Kang, HC; Kogan, SC; Shokat, K; Wolff, L; Braun, BS; Shannon, K. Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents. Proceedings of the National Academy of Sciences U S A, 2010, 107:5106-5111.
Wong, JC; Zhang, Y; Lieuw, KH; Tran, MT; Forgo, E; Weinfurtner, K; Alzamora, P; Kogan, SC; Akagi, K; Wolff, L; Le Beau, MM; Killeen, N; Shannon K. Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies. Blood, 2010, 115:4524-4532.
Zhao, Z; Zuber, J; Diaz-Flores, E; Lintault, L; Kogan, SC; Shannon, K; Lowe, SW. p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal. Genes & Development, 2010, 24:1389-1402.
Subramanyam, D; Belair, C; Barry-Holson, K; Lin, H; Kogan, S; Passegué, E; Blelloch, R. PML-RARα and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia. Cancer Research. 2010, 70:8792-8801.
Jones, L; Wei, G; Sevcikova, S; Phan, V; Jain, S; Shieh, A; Wong, JCY; Li, M; Dubansky, J; Maunakea, ML; Ochao, R; Zhu, G; Tennant, TR; Shannon, KM; Lowe, S; Le Beau, M; Kogan, SC. Gain of MYC Underlies Recurrent Trisomy of the MYC Chromosome in Acute Promyelocytic Leukemia. Journal of Experimental Medicine, 2010, 22:2581-2594.
Nakamura, JL; Phong, C; Pinarbasi, E; Kogan, SC; Vandenberg, S; Horvai, AE; Faddegon, BA; Fiedler, D; Shokat, K; Houseman, B; Chao, R; Pieper, RO; Shannon, K. Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. Cancer Research, 2011 71:106-115.